4.7 Article

Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 111, Issue 3, Pages 348-353

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2014.02.017

Keywords

Adaptive radiotherapy; Deformable image registration; Dose summation; IMRT; Dose-painting; Head-and-neck cancer

Funding

  1. Agency for Innovation by Science and Technology, Applied Biomedical Research [100774]
  2. Foundation against Cancer [2010-194]
  3. ABAS (Elekta CMS Software, Maryland Heights, MO)

Ask authors/readers for more resources

Purpose: The anatomical changes, which occur during the radiotherapy treatment for head-and-neck cancer, may compromise the effectiveness of the treatment. This study compares dosimetrical effects of adaptive (ART) and non-adaptive (RT) dose-painted radiotherapy. Materials and methods: For 10 patients, three treatment phases were preceded by a planning PET/CT scan. In ART, phases II and III were planned using PET/CT2 and PET/CT3, respectively. In RT, phases II and III were planned on PET/CT1 and recalculated on PET/CT2 and PET/CT3. Deformable image co-registration was used to sum the dose distributions and to propagate regions-of-interest (ROIs) drawn on PET/CT1 to PET/CT2, PET/CT3 and a last-treatment-day CT-scan. Results: Re-adjusted dose-painting ART provided higher minimum and lower maximum doses in target ROIs in comparison to RT. On average, ART reduced the parotids' median dose and swallowing structures mean dose by 4.6-7.1% (p > 0.05) and 3% (p = 0.06), respectively. Dose differences for targets were from -1.6% to 6.6% and for organs-at-risk from -7.1% to 7.1%. Analysis of individual patient data showed large improvements of ROI dose/volume metrics by ART, reaching a 24.4% minimum-dose increase in the elective neck planning target volume and 21.1% median-dose decrease in swallowing structures. Conclusion: Compared to RT, ART readjusts dose-painting, increases minimum and decreases maximum doses in target volumes and improves dose/volume metrics of organs-at-risk. The results favored the adaptive strategy, but also revealed considerable heterogeneity in patient-specific benefit. Reporting population-average effects underestimates the patient-specific benefits of ART. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Deep inspiration breath hold in the prone position retracts the heart from the breast and internal mammary lymph node region

Thomas Mulliez, Joris Van de Velde, Liv Veldeman, Werner De Gersem, Tom Vercauteren, Bruno Speleers, Henk Degen, Johan Wouters, Tom Van Hoof, Annick van Greveling, Chris Monten, Dieter Berwouts, Wilfried De Neve

RADIOTHERAPY AND ONCOLOGY (2015)

Article Oncology

Setup accuracy for prone and supine whole breast irradiation

Thomas Mulliez, Akos Gulyban, Tom Vercauteren, Annick van Greveling, Bruno Speleers, Wilfried De Neve, Liv Veldeman

STRAHLENTHERAPIE UND ONKOLOGIE (2016)

Article Otorhinolaryngology

Long-term outcome of 18F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study

Dieter Berwouts, Indira Madani, Frederic Duprez, AnaMaria Luiza Olteanu, Tom Vercauteren, Tom Boterberg, Philippe Deron, Katrien Bonte, Wouter Huvenne, Wilfried De Neve, Ingeborg Goethals

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Potential benefits of crawl position for prone radiation therapy in breast cancer

Bert Boute, Wilfried De Neve, Bruno Speleers, Annick Van Greveling, Christel Monten, Tom Van Hoof, Joris Van de Velde, Leen Paelinck, Werner De Gersem, Tom Vercauteren, Jan Detand, Liv Veldeman

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2017)

Article Oncology

Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial

Leen Paelinck, Akos Gulyban, Ferenc Lakosi, Tom Vercauteren, Werner De Gersem, Bruno Speleers, Christel Monten, Thomas Mulliez, Patrick Berkovic, Annick van Greveling, Frederik Decoster, Philippe Coucke, Wilfried De Neve, Liv Veldeman

RADIOTHERAPY AND ONCOLOGY (2017)

Article Engineering, Industrial

The relation between patient discomfort and uncompensated forces of a patient support device for breast and regional lymph node radiotherapy

Bert Boute, Liv Veldeman, Bruno Speleers, Annick Van Greveling, Tom Van Hoof, Joris Van de Velde, Tom Vercauteren, Wilfried De Neve, Jan Detand

APPLIED ERGONOMICS (2018)

Article Oncology

A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory

Julie Schatteman, Dirk Van Gestel, Dieter Berwouts, Werner De Gersem, Geert De Kerf, Wilfried De Neve, Bie De Ost, Ana Maria Luiza Olteanu, Sylvie Rottey, Tom Vercauteren, Ingeborg Goethals, Frederic Duprez

STRAHLENTHERAPIE UND ONKOLOGIE (2018)

Article Oncology

EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques

Katrien Vandecasteele, Philippe Tummers, Mieke Van Bockstal, Pieter De Visschere, Tom Vercauteren, Werner De Gersem, Hannelore Denys, Eline Naert, Amin Makar, Wilfried De Neve

BMC CANCER (2018)

Article Engineering, Biomedical

Deformation field validation and inversion applied to adaptive radiation therapy

Tom Vercauteren, Werner De Gersem, Luiza A. M. Olteanu, Indira Madani, Frederic Duprez, Dieter Berwouts, Bruno Speleers, Wilfried De Neve

PHYSICS IN MEDICINE AND BIOLOGY (2013)

Article Oncology

Hypofractionated whole breast irradiation for patients with large breasts: A randomized trial comparing prone and supine positions

Thomas Mulliez, Liv Veldeman, Annick van Greveling, Bruno Speleers, Simin Sadeghi, Dieter Berwouts, Frederik Decoster, Tom Vercauteren, Werner De Gersem, Rudy Van den Broecke, Wilfried De Neve

RADIOTHERAPY AND ONCOLOGY (2013)

Article Oncology

Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial

Dieter Berwouts, Luiza A. M. Olteanu, Frederic Duprez, Tom Vercauteren, Werner De Gersem, Wilfried De Neve, Christophe Van de Wiele, Indira Madani

RADIOTHERAPY AND ONCOLOGY (2013)

Article Oncology

Reliability and accuracy assessment of radiation therapy oncology group-endorsed guidelines for brachial plexus contouring

Joris Van de Velde, Tom Vercauteren, Werner De Gersem, Johan Wouters, Katrien Vandecasteele, Philippe Vuye, Frank Vanpachtenbeke, Katharina D'Herde, Ingrid Kerckaert, Wilfried De Neve, Tom Van Hoof

STRAHLENTHERAPIE UND ONKOLOGIE (2014)

Article Multidisciplinary Sciences

Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain

Bruno A. Speleers, Francesca M. Belosi, Werner R. De Gersem, Pieter R. Deseyne, Leen M. Paelinck, Alessandra Bolsi, Antony J. Lomax, Bert G. Boute, Annick E. Van Greveling, Christel M. Monten, Joris J. Van de Velde, Tom H. Vercauteren, Liv Veldeman, Damien C. Weber, Wilfried C. De Neve

SCIENTIFIC REPORTS (2019)

Article Oncology

Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer

Luiza Ana Maria Olteanu, Frederic Duprez, Wilfried De Neve, Dieter Berwouts, Tom Vercauteren, Wouter Bauters, Philippe Deron, Wouter Huvenne, Katrien Bonte, Ingeborg Goethals, Julie Schatteman, Werner De Gersem

ACTA ONCOLOGICA (2018)

Article Oncology

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group

Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala

Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn

Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang

Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research

Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai

Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner

Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma

Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia

Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.

RADIOTHERAPY AND ONCOLOGY (2024)

Review Oncology

Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review

Xiaoyong Xiang, Zhe Ji, Jing Jin

Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts

M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit

Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques

Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman

Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy

Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost

Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Primer shot fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer

Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy

Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity

Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni

Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

The rise of negative portrayals of radiation oncology: A textual analysis of media news

Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka

Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses

Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin

Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.

RADIOTHERAPY AND ONCOLOGY (2024)

Article Oncology

Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)

Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes

Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.

RADIOTHERAPY AND ONCOLOGY (2024)